Insights

Wesfarmers (ASX:WES) share price in focus as investors await next move

The Wesfarmers share price is on watch as the conglomerate enters a bidding war for API.
The post Wesfarmers (ASX:WES) share price in focus as investors await next move appeared first on The Motley Fool Australia. –

The Wesfarmers Ltd (ASX: WES) share price has had a rough time recently and investors have it firmly on watch.

In early trade this morning, the Wesfarmers share price is in positive territory. It’s up 0.96% to $55.84.

So, why are investors paying such close attention to the Wesfarmers share price?

Investors waiting for Wesfarmers to make next move on API

The Wesfarmers share price has been rocked by various events in this past week.

Most notably was the news of a rival bid for Australian Pharmaceutical Industries Ltd (ASX: API).

Listed pharmaceutical company Sigma Healthcare Ltd (ASX: SIG) entered the race with a bid for 100% of API shares at $1.57 per share.

Sigma’s offer includes cash of 35 cents per share and 2.05 Sigma shares per API share.

By comparison, Wesfarmers recently sweetened its bid to acquire API, tabling an offer of $1.55 per share under a revised scheme arrangement.

As a result, a bidding war has emerged with both Sigma and Wesfarmers simultaneously undertaking due diligence.

The higher bid from Sigma has awakened speculation that Wesfarmers could lob a higher cash bid.

Interestingly, API’s major shareholder Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) could have a role to play.

Soul Patts has agreed to vote its 19.3% shareholding in API in favour of Wesfarmers’ revised proposal. 

As a result, the conglomerate has the right to exercise a call option if it matches a bid by Sigma.

However, there remains uncertainty as to what form an equivalent offer could take.

More on the Wesfarmers share price

Up until recently, the Wesfarmers share price was having a stellar year.

However, in the past month shares in the conglomerate have fallen more than 16% from their record highs.

The main catalyst can be attributed to the conglomerate’s full-year report.

Despite delivering solid growth in FY21, Wesfarmers flagged that earnings in the group’s retail businesses for the first half of FY22 may be below the prior corresponding period.

As a result, investors may be questioning the outlook for shares in Wesfarmers.

The post Wesfarmers (ASX:WES) share price in focus as investors await next move appeared first on The Motley Fool Australia.

Should you invest $1,000 in Wesfarmers right now?

Before you consider Wesfarmers, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Wesfarmers wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Here are 2 ASX dividend shares that could provide steady passive income

Why Sigma, Smartgroup, St Barbara, & Touch Ventures are pushing higher

Wesfarmers (ASX:WES) share price wobbles amid rival bid for API
Why AVZ, Flight Centre, Fortescue, & Sigma shares are storming higher

Woolworths (ASX:WOW) and Coles (ASX:COL) could face a margin shock

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Washington H. Soul Pattinson and Company Limited and Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!